基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 5,308.27
成立日期: 26/01/2004
 
分析
市值分佈:
94.15%
大市值
2.37%
中市值
0.58%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 18/07/2026 05:44) 總持有投資項目: 384  
0%
 
100%
     10大 (52.10%)
代號 名稱 佔比% 持有日期
CLOVClover Health Investments Corp0.0330/06/2026
XRAYDENTSPLY SIRONA0.0330/06/2026
MDPediatrix Medical Group0.0330/06/2026
BCRXBioCryst Pharmaceuticals0.0330/06/2026
ASTHAstrana Health0.0330/06/2026
AGIOAgios Pharmaceuticals0.0330/06/2026
NAMSNewAmsterdam Pharma Company NV0.0330/06/2026
LMATLeMaitre Vascular0.0330/06/2026
UFPTUFP Technologies0.0330/06/2026
SMMTSummit Therapeutics0.0330/06/2026
IMNMImmunome0.0330/06/2026
ALMSAlumis Inc.0.0330/06/2026
NEONeoGenomics0.0330/06/2026
LFSTLifeStance Health Group0.0330/06/2026
TARSTarsus Pharmaceuticals0.0330/06/2026
NEOGNeogen Corp0.0330/06/2026
ADMAADMA Biologics0.0330/06/2026
OMCLOmnicell0.0330/06/2026
VERAVera Therapeutics0.0330/06/2026
ADUSAddus HomeCare Corp0.0330/06/2026
  1    2    3    4    5    6    7    8   9    10    11    12    13    14    15    16    17    18    19    20  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.